The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
1/10000 - 1/50000. Detects a band of approximately 66 kDa (predicted molecular weight: 66 kDa).
Is unsuitable for Flow Cyt,ICC/IF,IHC-P or IP.
Cell surface proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition.
Highly expressed in lung, liver and kidney.
Involvement in disease
Defects in GPC3 are the cause of Simpson-Golabi-Behmel syndrome type 1 (SGBS1) [MIM:312870]; also known as Simpson dysmorphia syndrome (SDYS). SGBS is a condition characterized by pre- and postnatal overgrowth (gigantism) with visceral and skeletal anomalies.
Cartier F et al. New tumor suppressor microRNAs target glypican-3 in human liver cancer. Oncotarget8:41211-41226 (2017).
WB, Flow Cyt
Read more (PubMed: 28476031) »
Liu W et al. Hepatic epithelioid angiomyolipoma is a rare and potentially severe but treatable tumor: A report of three cases and review of the literature. Oncol Lett11:3669-3675 (2016).
Read more (PubMed: 27313680) »